DiRx, an East Brunswick, N.J.-based online pharmacy platform that delivers savings on commonly prescribed, FDA-approved generic medicines without the need for insurance, raised $5.75m in Series A funding.
The backers were not disclosed.
The company intends to use the funds to expand its innovative digital pharmacy business recently launched nationally.
Led by Satish Srinivasan, Founder and CEO, and Simone Grapini-Goodman, Chief Marketing Officer, DiRx is an online pharmacy that delivers savings on commonly prescribed, FDA-approved generic medicines without the need for insurance.
The company’s model reduces the number of supply chain layers and offers low priced options for over 1,000 FDA-approved prescription generic medications, without requiring health insurance. DiRx offers a 12-months price guarantee. In addition to its direct -to-consumer digital platform, DiRx is also gaining traction with institutional partnerships that would offer similar cost advantages to larger groups in traditional as well as digital health ecosystems.